Pulmonary hypertension - the latest updates for physicians

Clin Med (Lond). 2023 Sep;23(5):449-454. doi: 10.7861/clinmed.2023-23.5.Cardio4.

Abstract

Pulmonary hypertension (PH) is common, with an estimated prevalence of approximately 1% that increases with age. Prompt and accurate diagnosis is key to institute timely and appropriate therapy to improve symptoms and prognosis. The international guidelines for the diagnosis and management of PH have recently been updated, with a lowering of the haemodynamic threshold for diagnosis to a mean pulmonary artery pressure >20 mmHg. New diagnostic algorithms and revised indications for screening in at-risk groups have been developed to facilitate early referral to specialist PH centres. This includes fast-track referral pathways for patients who are either clinically high-risk or are at-risk for pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH). This review summarises key changes in the PH guidelines for general physicians who are, most often, the first healthcare professionals to encounter these patients and consequently have a key role as referrers into specialist PH services.

Keywords: Pulmonary hypertension; chronic thromboembolic pulmonary hypertension; pulmonary arterial hypertension; screening; systemic sclerosis.

Publication types

  • Review

MeSH terms

  • Chronic Disease
  • Humans
  • Hypertension, Pulmonary* / diagnosis
  • Hypertension, Pulmonary* / etiology
  • Hypertension, Pulmonary* / therapy
  • Physicians*
  • Prognosis